RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Trasduzione del segnale, meccanismi di plasticita' e neurodegenerazione nella malattia di Alzheimer
• 2 - Morbo di Alzheimer e Patologia di Tau e Beta-Amiloide: studi in vitro, in vivo e comportamentali
• 3 - EFFETTI COMPORTAMENTALI, CELLULARI E MOLECOLARI DELLE ACILETANOLAMIDI ENDOGENE
• 4 - COMPLICANZE OSTETRICHE DA ANTICORPI ANTI-FOSFOLIPIDI: meccanismi patogenetici molecolari quali nuovi target terapeutici e marcatori prognostici.
• 5 - Nuove conoscenze fisiopatologiche per nuove prospettive terapeutiche del colangiocarcinoma
• 6 - Somatostatina e peptidi correlati: distribuzione, effetti biologici e caratterizzazione di modelli transgenici
• 7 - Studi struttura-funzione sulle neurotrofine e loro precursori nella funzione presinaptica, nella epilettogenesi e nella neurogenesi adulta
• 8 - Meccanismi molecolari delle neurotrofine e dei loro precursori nella plasticità sinaptica e nella neurodegenerazione
• 9 - Fisiopatologia della proteina prionica: nuovi approcci di studio in vitro ed in vivo
• 10 - Endocrine disruptorse modificazioni delle funzioni neuroendocrine,metaboliche e del comportamento:ruolo della somministrazione bifeniili policlorurati(PCB)durante lo sviluppo

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze biologiche
  • FISIOLOGIA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY (installation for fermenting manure A01C3/02; preservation of living parts of humans or animals A01N1/02; physical or chemical apparatus in general B01; malting or mashing apparatus C12C1/00; brewing apparatus C12C13/00; fermentation apparatus for wine C12G; apparatus for preparing vinegar C12J1/10)
  • ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
    • PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

Classificazione geografica

• Regione: Abruzzo

Bibliografia

Alonso A, de Curtis M, Llinas R. (1990) Postsynaptic Hebbian and non-Hebbian long-term potentiation of synaptic efficacy in the entorhinal cortex in slices and in the isolated adult guinea pig brain. Proc Natl Acad Sci U S A 87: 9280-9284

Arancio O, Zhang HP, Chen X, Lin C, Trinchese F, Puzzo D, Liu S, Hegde A, Yan SF, Stern A, Luddy JS, Lue LF, Walker DG, Roher A, Buttini M, Mucke L, Li W, Schmidt AM, Kindy M, Hyslop PA, Stern DM, Du Yan SS (2004) RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J 23: 4096-4105

Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 3:213-216.

Braak H, Braak E (1993) Entorhinal-hippocampal interaction in mnestic disorders.Hippocampus 3:239-246

Chen QS, Wei WZ, Shimahara T, Xie CW (2002) Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem 3:354-71

Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9: 907-913


Eisenhauer PB, Johnson RJ, Wells JM, Davies TA, Fine RE (2000) Toxicity of various amyloid beta peptide species in cultured human blood-brain barrier endothelial cells: increased toxicity of dutch-type mutant. J Neurosci Res 60: 804-810

Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889–901

Kirkwood A, Bear MF (1994) Hebbian synapses in visual cortex. J Neurosci 14:1634-1645

Kirkwood A, Bear MF (1995) Elementary forms of synaptic plasticity in the visual cortex. Biol Res 28:73-80

Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH (2002) The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A. 18: 11830-11835

Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD (2001) Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp Neurol 171: 29-45.

Mielke R, Kessler J, Fink G, Herholz K, Heiss WD (1995) Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease. Int J Neurosci 82: 1-9

Morrison JH, Hof PR, Bouras C (1991) An anatomic substrate for visual disconnection in Alzheimer's disease. Ann N Y Acad Sci 640: 36-43.

Origlia N, Capsoni S, Cattaneo A, Domenici L (2006) Time window in cholinomimetic ability to rescue LTP in neurodegenerating anti-NGF mice. J Alzheimers Dis 9: 59-68

Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K,Winblad B, Cowburn RF (2001) Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer’s disease brains at different stages of neurofibrillary degeneration. J Alzheimers Dis 3: 41–48

Pesavento E, Margotti E, Righi M, Cattaneo A, Domenici L (2000). Blocking the NGF-TrkA interaction rescues the developmental loss of LTP in the rat visual cortex: role of the cholinergic system. Neuron 25: 165-175.

Pesavento E, Capsoni S, Domenici L, Cattaneo A (2002) Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-Nerve Growth Factor mice. Eur J Neurosci 15: 1030-1036

Raymond CR, Ireland DR, Abraham WC (2003) NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus. Brain Res 2: 263-272

Rizzo M, Anderson SW, Dawson J, Nawrot M (2000) Vision and cognition in Alzheimer's disease. Neuropsychologia 3: 1157-1169

Schmidt AM, Yan SD, Yan SF, Stern DM (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest.108:949-955

Sjogren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelso C, Skoog I, Wallin A, Wahlund LO, Marcusson J, Nagga K, Andreasen N, Davidsson P, Vanmechelen E, Blennow K (2001) Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem 47:1776-1781

Suzuki WA, Amaral DG (2004) Functional neuroanatomy of the medial temporal lobe memory system. Cortex 40: 220-222

Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, Viola KL, Klein WL, Stine WB, Krafft GA, Trommer BL (2002) Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924: 133-140

Witter MP, Groenewegen HJ, Lopes da Silva FH, Lohman AH (1989) Functional organization of the extrinsic and intrinsic circuitry of the parahippocampal region. Prog Neurobiol 33: 161-253

Witter MP (1993) Organization of the entorhinal-hippocampal system: a review of current anatomical data. Hippocampus 3: 33–44

Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier J, Stern DM. (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med 1: 693-699

Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.

Yun SH, Huh K, Jung MW (2000) Selective enhancement of non-NMDA receptor-mediated responses following induction of long-term potentiation in entorhinal cortex. Synapse 35: 1–7

Yun SH, Jung IM, Jung MW (2002) Variation in effective stimulus pattern for induction of long- term potentiation across different layers of rat entorhinal cortex. J Neurosci 22: RC214

Parole Chiave

BETA AMILOIDE, RAGE, NEURODEGENERAZIONE, PLASTICITÀ SINAPTICA, CORTECCIA ENTORINALE, POTENZIAMENTO A LUNGO TERMINE, MAP CHINASI, FUNZIONI COGNITIVE